Duodenal Eosinophilia in Functional Dyspepsia

Aim: to present observation of a patient diagnosed with functional dyspepsia based on current guidelines, and having increased eosinophil counts in the biopsy specimen of duodenal mucosa. To consider possible causes of duodenal eosinophilia in the light of present-day concepts.

Highlights. Patient K., 40 years old, complained of dyspeptic phenomena, the first appearance of which she had noted at the age of 18. The patient noted poor tolerance to canned and fermented foods, which provoked an increase in dyspepsia and sometimes caused watery diarrhea. The examination excluded “symptoms of concern”. Successful antihelicobacter eradication therapy was carried out. Morphological examination of the stomach showed phenomena of mild chronic inflammation without intestinal metaplasia or glandular atrophy. A biopsy of the mucosa of the descending part of the duodenum showed a moderate increase in the levels of mononuclears and eosinophils in its lamina propria without penetration into the epithelium of the villi or formation of clusters. The patient suffers from pollinosis; sensitization to birch pollen was diagnosed by a skin prick test. However, she has no oral allergy symptoms, which does not allow linking duodenal eosinophilia to food allergy. Based on current guidelines, the patient was diagnosed with functional dyspepsia. In addition to dietary restrictions, treatment courses with a proton pump inhibitor, itopride, and S-methylmethionine sulfonium chloride, which has an antihistamine effect, were recommended for periods of worsening dyspepsia.

Conclusion. The clinical significance of duodenal eosinophilia and local histamine production in patients with a clinical diagnosis of functional dyspepsia deserves special attention. Triggering factors provoking the worsening of symptoms should be analyzed; in particular, a food diary and exclusion of food allergies are recommended. Histamine-neutralizing drugs may play a role in the treatment of FD with duodenal eosinophilia in the future.

1. Ceulemans M., Jacobs I., Wauters L., Vanuytsel T. Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect. Front Neurosci. 2022;16:831761. DOI: 10.3389/fnins.2022.831761

2. Wauters L., Ceulemans M., Vanuytsel T. Duodenum at a crossroads: Key integrator of overlapping and psychological symptoms in functional dyspepsia? Neurogastroenterol Motil. 2021;33(10):e14262. DOI: 10.1111/nmo.14262

3. Ivashkin V.T., Mayev I.V., Sheptulin A.A., Lapina T.L., Trukhmanov A.S., Kartavenko I.M., et al. Diagnosis and treatment of the functional dyspepsia: clinical guidelines of the Russian Gastroenterological Association. Ross. z gastroenterol, gepatol, koloproktol. 2017;27(1):50—61 (In Russ.). DOI: 10.22416/1382-4376-2017-27-1-50-61

4. Ivashkin V.T., Maev I.V., Lapina T.L., Fedorov E.D., Sheptulin A.A., Trukhmanov A.S., et al. Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis. Ross. z gastroenterol, gepatol, koloproktol. 2021;31(4):70-99 (In Russ.). DOI: 10.22416/1382-4376-2021-31-4-70-99

5. Chaudhari A.A., Rane S.R., Jadhav M.V. Histomorphological Spectrum of Duodenal Pathology in Functional Dyspepsia Patients. J Clin Diagn Res. 2017;11(6):EC01-4. DOI: 10.7860/JCDR/2017/25297.9985

6. Turner K.O., Collins M.H., Walker M.M., Genta R.M. Quantification of Mucosal Eosinophils for the Histopathologic Diagnosis of Eosinophilic Gastritis and Duodenitis: A Primer for Practicing Pathologists. The American Journal of Surgical Pathology. 2022;46(4):557-66. DOI: 10.1097/PAS.0000000000001843

7. lsson S., Talley N.J., Holtmann G. Eosinophilic Gastritis and Eosinophilic Duodenitis. Curr Treat Options Gastro. 2022;20:501-11. DOI: 10.1007/s11938-022-00392-z

8. Jimenez-Saiz R., Anipindi V.C., Galipeau H., Ellenbogen Y., Chaudhary R., Koenig J.F., et al. Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity. Front Immunol. 2020;11:155. DOI: 10.3389/fimmu.2020.00155

9. Shah A., Fairlie T., Brown D., Jones M.P., Eslick G.D., Duncanson K., et al. Duodenal Eosinophils and Mast Cells in Functional Dyspepsia: A Systematic Review and Meta-Analysis of Case-Control Studies. Clinical Gastroenterology and Hepatology. 2022;20:2229-42.e29. DOI: 10.1016/j.cgh.2022.01.014

10. Lee M.J., Jung H.K., Lee K.E., Mun Y.C., Park S. Degranulated Eosinophils Contain More Fine Nerve Fibers in the Duodenal Mucosa of Patients With Functional Dyspepsia. J Neurogastroenterol Motil. 2019;25(2):212-21. DOI: 10.5056/jnm18176

11. Comas-Baste O., Sanchez-Perez S., Veciana-Nogues M.T., Latorre-Moratalla M., Vidal-Carou M.D.C. Histamine Intolerance: The Current State of the Art. Biomolecules. 2020;10(8):1181. DOI: 10.3390/biom10081181

12. Wechsler J.B., Szabo A., Hsu C.L., Krier-Burris R.A., Schroeder H.A., Wang M.Y., et al. Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis. Mucosal Immunol. 2018;11(3):861-70. DOI: 10.1038/mi.2017.121

13. Shanahan E.R., Kang S., Staudacher H., Shah A., Do A., Burns G., et al. Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia. Gut. 2022. DOI: 10.1136/gutjnl-2021-326158

14. Vanuytsel T., Bercik P., Boeckxstaens G. Understanding neuroimmune interactions in disorders of gut-brain interaction: from functional to immune-mediated disorders. Gut. 2023; 72(4):787-98. DOI: 10.1136/gutjnl-2020-320633

15. Koloski N., Jones M., Walker M.M., Veysey M., Zala A., Keely S., et al. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Aliment Pharmacol Ther. 2019;49(5):546-55. DOI: 10.1111/apt.15120

16. Jones M.P., Walker M.M., Ford A.C., Talley N.J. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther. 2014;40(4):382-91. DOI: 10.1111/apt.12846

17. Hogerle C., San Nicolo M., Gellrich D., Eder K., Groger M. Clinical Relevance of Profilin Sensitization Concerning Oral Allergy Syndrome in Birch Pollen Sensitized Patients. J Asthma Allergy. 2022;15:249-55. DOI: 10.2147/JAA.S348650

18. Kanikowska A., Janisz S., Mankowska-Wierzbicka D., Gabryel M., Dobrowolska A., Eder P. Management of Adult Patients with Gastrointestinal Symptoms from Food Hypersensitivity-Narrative Review. J Clin Med. 2022;11(24):7326. DOI: 10.3390/jcm11247326

19. Wauters L., Ceulemans M., Schol J., Farre R., Tack J., Vanuytsel T. The Role of Leaky Gut in Functional Dyspepsia. Front Neurosci. 2022 Mar 29;16:851012. DOI: 10.3389/fnins.2022.851012

20. Vandenberghe A., Schol J., Van den Houte K., Masuy I., Carbone F., Tack J. Current and emerging therapeutic options for the management of functional dyspepsia. Expert Opinion on Pharmacotherapy. 2020;21(3):365-76. DOI: 10.1080/14656566.2019.1707805

21. Ford A.C., Mahadeva S., Carbone M.F., Lacy B.E., Talley N.J. Functional dyspepsia. The Lancet. 2020;396:1689-702. DOI: 10.1016/s0140-6736(20)30469-4

22. Potter M.D.E., Goodsall T.M., Walker M.M., Talley N.J. Dual histamine blockade for the treatment of adult functional dyspepsia: a single centre experience. Gut. 2019;69(5):966.

23. Chaves J., Pita I., Libanio D., Pimentel-Nunes P. Pharmacological Treatment of Functional Dyspepsia: An Old Story Revisited or a New Story to Be Told? A Clinical Review. GE Port J Gastroenterol. 2022. DOI: 10.1159/000526674

24. Watanabe T., Ohara S., Miyazawa S., Saigenji K., Hotta K. Augmentative effects of L-cysteine and methylmethionine sulphonium chloride on mucin secrecion in rabbit gastric mucous cells. J Gastroenterol Hepatol. 2000;15(1):45-52. DOI: 10.1046/j.1440-1746.2000.02037

25. Magierowska K., Korbut E., Wojcik-Grzybek D., Bakalarz D., Sliwowski Z., Cieszkowski J., et al. Mitochondria-targeted hydrogen sulfide donors versus acute oxidative gastric mucosal injury. J Control Release. 2022 Aug;348:321-34. DOI: 10.1016/j.jconrel.2022.05.051

26. Asha D., Patel A.D., Prajapati N.K. Review on Biochemical Importance of Vitamin U. J Chem Pharm Res. 2012;4(1):209-15.